| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | A11HA06 |
| UNII: | F06SGE49M6 |
| InChI Key | NGVDGCNFYWLIFO-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C8H12NO7P |
| Molecular Weight | 265.16 |
| AlogP | 0.52 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 116.95 |
| Molecular species | ACID |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 16.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Phosphatase
Protein Phosphatase
Tyrosine protein phosphatase
|
- | - | - | 13000 | - | |
|
Ion channel
Ligand-gated ion channel
P2X receptor
|
3000 | 10000 | - | - | 13 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Movement Disorders | 2 | D009069 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 18405 |
| ChEMBL | CHEMBL82202 |
| DrugBank | DB00114 |
| DrugCentral | 3506 |
| EPA CompTox | DTXSID4048351 |
| FDA SRS | F06SGE49M6 |
| Human Metabolome Database | HMDB0001491 |
| Guide to Pharmacology | 5249 |
| KEGG | C00018 |
| PDB | PLP |
| PharmGKB | PA164749650 |
| PubChem | 38882 |
| SureChEMBL | SCHEMBL23158 |
| ZINC | ZINC000001532514 |
| ChEMBL | CHEMBL3181870 |
| EPA CompTox | DTXSID7046594 |
| FDA SRS | 5V5IOJ8338 |
| PubChem | 38882 |
| SureChEMBL | SCHEMBL827100 |